Cell Therapy News/Articles, page-1461

$5 that's just the start!

I remembered @otherperspective mentioning about the butterfly process - I loved it, very well written by OP.

Anyway, the point is Mesoblast is largely undervalued and an unknown.
All the SP targets do not even do justice to Mesoblast suite of products prior to Covid-19...

But, now it is a different ball game.
Mesoblast name is starting to be blasted everywhere and will continue to be escalated.
Being involved with the Covid-19 has finally put some limelight into Mesoblast, and now it has the word "Global" next to it.

I still see $20 by the end of the year and that without incorporating in the Covid-19 additional SP value.

Mesoblast involvement with Covid-19 is still fresh and many of the respected analysts have not yet incorporated this in their TPs... so watch this space - for the analyst revisions to come

News, news and more new on Mesoblast

GLTASHs
$20 sounds crazy atm, but have a go at evaluating Mesoblast value yourself - you'll be pleasantly surprised